Cost Plus Drugs Offers Big Savings on Humira Biosimilar Yusimry

July 17, 2023

Cost Plus Drugs, co-founded by Mark Cuban and radiologist Alexander Oshmyansky, will provide customers the ability to purchase Yusimry, a biosimilar for Humira, for $569.27 plus dispensing and shipping fees. Humira is currently priced at $6,922 for the same quantity.

Members of Cost Plus Drugs can get Yusimry at this discounted price, as can members of RxPreferred and SmithRx, two pharmacy benefits administrators who have partnered with Cost Plus Drugs.

This pricing by Cost Plus Drugs makes it easier and more affordable for patients to get the treatment they need. Cuban said the company hopes to provide other biosimilar drugs as well. “Our mission is to be the low-cost provider of any and all medications we are able to carry,” he wrote.

References:

• RxPreferred to Offer Yusimry Through Mark Cuban Cost Plus Drug Company (formularywatch.com)
• Mark Cuban’s online pharmacy set to launch Humira biosimilar (Reuters.com)).
• Mark Cuban’s Drug Company Will Launch Yusimry at 85% Discount | Forbes.com
• Mark Cuban Cost Plus Drug Company joins forces with Coherus (globenewswire.com)
• Mark Cuban Cost Plus Drugs
• Patient Support and Prescription Assistance Programs | Spondylitis.org